152 related articles for article (PubMed ID: 18216775)
21. Amitriptyline preserves morphine's antinociceptive effect by regulating the glutamate transporter GLAST and GLT-1 trafficking and excitatory amino acids concentration in morphine-tolerant rats.
Tai YH; Wang YH; Tsai RY; Wang JJ; Tao PL; Liu TM; Wang YC; Wong CS
Pain; 2007 Jun; 129(3):343-354. PubMed ID: 17346885
[TBL] [Abstract][Full Text] [Related]
22. D-2-amino-5-phosphonopentanoic acid inhibits intrathecal pertussis toxin-induced thermal hyperalgesia and protein kinase Cgamma up-regulation.
Wen ZH; Guo YW; Chang YC; Wong CS
Brain Res; 2003 Feb; 963(1-2):1-7. PubMed ID: 12560106
[TBL] [Abstract][Full Text] [Related]
23. Intrathecal co-administration of morphine and nimodipine produces higher antinociceptive effect by synergistic interaction as evident by injecting different doses of each drug in rats.
Gupta H; Verma D; Ahuja RK; Srivastava DN; Wadhwa S; Ray SB
Eur J Pharmacol; 2007 Apr; 561(1-3):46-53. PubMed ID: 17320072
[TBL] [Abstract][Full Text] [Related]
24. Lipoxin A4 analog attenuates morphine antinociceptive tolerance, withdrawal-induced hyperalgesia, and glial reaction and cytokine expression in the spinal cord of rat.
Jin H; Li YH; Xu JS; Guo GQ; Chen DL; Bo Y
Neuroscience; 2012 Apr; 208():1-10. PubMed ID: 22366510
[TBL] [Abstract][Full Text] [Related]
25. Resveratrol regulates N-methyl-D-aspartate receptor expression and suppresses neuroinflammation in morphine-tolerant rats.
Tsai RY; Chou KY; Shen CH; Chien CC; Tsai WY; Huang YN; Tao PL; Lin YS; Wong CS
Anesth Analg; 2012 Oct; 115(4):944-52. PubMed ID: 22713680
[TBL] [Abstract][Full Text] [Related]
26. Increasing of intrathecal CSF excitatory amino acids concentration following morphine challenge in morphine-tolerant rats.
Wen ZH; Chang YC; Cherng CH; Wang JJ; Tao PL; Wong CS
Brain Res; 2004 Jan; 995(2):253-9. PubMed ID: 14672815
[TBL] [Abstract][Full Text] [Related]
27. Amitriptyline suppresses neuroinflammation-dependent interleukin-10-p38 mitogen-activated protein kinase-heme oxygenase-1 signaling pathway in chronic morphine-infused rats.
Tai YH; Tsai RY; Lin SL; Yeh CC; Wang JJ; Tao PL; Wong CS
Anesthesiology; 2009 Jun; 110(6):1379-89. PubMed ID: 19417613
[TBL] [Abstract][Full Text] [Related]
28. An antisense oligonucleotide to the N-methyl-D-aspartate (NMDA) subunit NMDAR1 attenuates NMDA-induced nociception, hyperalgesia, and morphine tolerance.
Shimoyama N; Shimoyama M; Davis AM; Monaghan DT; Inturrisi CE
J Pharmacol Exp Ther; 2005 Feb; 312(2):834-40. PubMed ID: 15388787
[TBL] [Abstract][Full Text] [Related]
29. Intrathecally injected morphine inhibits inflammatory paw edema: the involvement of nitric oxide and cyclic-guanosine monophosphate.
Brock SC; Tonussi CR
Anesth Analg; 2008 Mar; 106(3):965-71, table of contents. PubMed ID: 18292447
[TBL] [Abstract][Full Text] [Related]
30. Intrathecal pertussis toxin produces hyperalgesia and allodynia in mice.
Womer DE; DeLapp NW; Shannon HE
Pain; 1997 Apr; 70(2-3):223-8. PubMed ID: 9150297
[TBL] [Abstract][Full Text] [Related]
31. Spinal amino acid release and repeated withdrawal in spinal morphine tolerant rats.
Ibuki T; Marsala M; Masuyama T; Yaksh TL
Br J Pharmacol; 2003 Feb; 138(4):689-97. PubMed ID: 12598423
[TBL] [Abstract][Full Text] [Related]
32. Ketorolac prevents recurrent withdrawal induced hyperalgesia but does not inhibit tolerance to spinal morphine in the rat.
Dunbar SA; Karamian I; Zhang J
Eur J Pain; 2007 Jan; 11(1):1-6. PubMed ID: 16448827
[TBL] [Abstract][Full Text] [Related]
33. Chronic morphine induces downregulation of spinal glutamate transporters: implications in morphine tolerance and abnormal pain sensitivity.
Mao J; Sung B; Ji RR; Lim G
J Neurosci; 2002 Sep; 22(18):8312-23. PubMed ID: 12223586
[TBL] [Abstract][Full Text] [Related]
34. Monoamine-dependent, opioid-independent antihypersensitivity effects of intrathecally administered milnacipran, a serotonin noradrenaline reuptake inhibitor, in a postoperative pain model in rats.
Obata H; Kimura M; Nakajima K; Tobe M; Nishikawa K; Saito S
J Pharmacol Exp Ther; 2010 Sep; 334(3):1059-65. PubMed ID: 20558774
[TBL] [Abstract][Full Text] [Related]
35. The effect of morphine on formalin-evoked behaviour and spinal release of excitatory amino acids and prostaglandin E2 using microdialysis in conscious rats.
Malmberg AB; Yaksh TL
Br J Pharmacol; 1995 Mar; 114(5):1069-75. PubMed ID: 7780642
[TBL] [Abstract][Full Text] [Related]
36. Lack of reciprocity between opioid and 5-HT3 receptors for antinociception in rat spinal cord.
Yoon MH; Bae HB; Choi JI; Kim SJ; Chung ST; Kim CM
Pharmacology; 2006; 77(4):195-202. PubMed ID: 16874010
[TBL] [Abstract][Full Text] [Related]
37. Central antinociceptive effects of non-steroidal anti-inflammatory drugs and paracetamol. Experimental studies in the rat.
Björkman R
Acta Anaesthesiol Scand Suppl; 1995; 103():1-44. PubMed ID: 7725891
[TBL] [Abstract][Full Text] [Related]
38. Ultra-low-dose naloxone suppresses opioid tolerance, dependence and associated changes in mu opioid receptor-G protein coupling and Gbetagamma signaling.
Wang HY; Friedman E; Olmstead MC; Burns LH
Neuroscience; 2005; 135(1):247-61. PubMed ID: 16084657
[TBL] [Abstract][Full Text] [Related]
39. Dextromethorphan potentiates morphine antinociception at the spinal level in rats.
Chow LH; Huang EY; Ho ST; Lee TY; Tao PL
Can J Anaesth; 2004 Nov; 51(9):905-10. PubMed ID: 15525615
[TBL] [Abstract][Full Text] [Related]
40. Antinociceptive potentiation and attenuation of tolerance by intrathecal electric stimulation in rats.
Lin CR; Yang LC; You HL; Lee CT; Tai MH; Tan PH; Lin MW; Cheng JT
Anesth Analg; 2003 Jun; 96(6):1711-1716. PubMed ID: 12761002
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
